![](/img/cover-not-exists.png)
Resistance to the CHK1 inhibitor prexasertib involves functionally distinct CHK1 activities in BRCA wild-type ovarian cancer
Nair, Jayakumar, Huang, Tzu-Ting, Murai, Junko, Haynes, Brittany, Steeg, Patricia S., Pommier, Yves, Lee, Jung-MinJournal:
Oncogene
DOI:
10.1038/s41388-020-1383-4
Date:
July, 2020
File:
PDF, 4.77 MB
2020